Other news
News
Partner news
MacroGenics Enters Research Collaboration with Janssen to Develop Novel DART® Molecule
Read full storyOther news
XWPharma Names Michael M. Morrissey, PhD to Board of Directors
Read full storyPartner news
Australian National University Announces Research Project with Janssen to Help Develop New Methods for Measuring and Monitoring Type 1 Diabetes
Read full storyPartner news
Symvivo Corporation Announces Research Agreement with Janssen to Offer Novel Approach to Therapeutic Protein Delivery
Read full storyPartner news
CHO Plus Announces Research Collaboration Agreement with Janssen to Improve Manufacturing of Therapeutic Proteins
Read full storyPartner news
UK Biobank launches one of the largest scientific studies measuring circulating proteins, to better understand the link between genetics and human disease
Read full storyPartner news
Xencor Enters Collaboration with Janssen with Aim to Discover Novel CD28 Bispecific Antibodies for the Treatment of Prostate Cancer
Read full storyPartner news
Janssen Acquires Rights to Novel Gene Therapy, Pioneering Treatment Solutions for Late-Stage Age-Related Macular Degeneration
Read full storyPartner news
Johnson & Johnson Acquires TARIS Biomedical with Focus on Transforming the Treatment of Bladder Cancer
Read full storyPartner news
Johnson & Johnson Announces Agreement to Acquire Remaining Stake in Verb Surgical Inc.
Read full storyPartner news
Zebra Medical Vision Announces Agreement With DePuy Synthes to Deploy Cloud Based Artificial Intelligence Orthopaedic Surgical Planning Tools
Read full storyIn the media
At the Bio-Europe conference in Hamburg last month, experts weighed in on the challenges and future of neuroscience
Read full storyPartner news
Janssen to Acquire Investigational Bermekimab from XBiotech
Read full storyOther news